Mar 14, 2016

Global Next-Generation Sequencing (NGS) Market Worth USD 10,371.1 Million by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: 454 Life Sciences, Agilent Technologies, Illumina - Research and Markets March 14, 2016 10:25 AM Eastern Daylight Time DUBLIN--( BUSINESS WIRE )--Research and Markets ( http://www.researchandmarkets.com/research/6c73qm/nextgeneration ) has announced the addition of the "Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo),Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021" report to their offering. The next generation sequencing market is expected to reach USD 10,371.1 Million by 2021 from USD 4,031.7 Million in 2016, at a CAGR of 20.8% between 2016 and 2021. The drivers for the NGS market include technological advancements in NGS products, increasing applications of NGS, entry of new market players, and increasing partnerships & collaborations among market players plus growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders. This report segments the global NGS market into products & services, technology, application, and end user. The NGS market, by products & services is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The pre-sequencing products & services segment if further categorized into DNA fragmentation. End repair, A-tailing, & size selection; library preparation & target enrichment; and quality control. Companies Mentioned: 454 Life Sciences Corporation (Roche Holding AG) Agilent Technologies, Inc.